Chemical beauty contest

Paul Leeson ()
Additional contact information
Paul Leeson: Paul Leeson is at the GlaxoSmithKline Medicines Research Centre, Stevenage SG1 2NY, UK.

Nature, 2012, vol. 481, issue 7382, 455-456

Abstract: Most drug candidates fail clinical trials, in many cases because the compounds have less than optimal physico-chemical properties. A new method for assessing the 'drug-likeness' of compounds might help to remedy the situation.

Date: 2012
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/481455a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:481:y:2012:i:7382:d:10.1038_481455a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/481455a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().